PAS
PCVX icon

Point72 Asia (Singapore)’s Vaxcyte PCVX Stock Holding History

Point72 Asia (Singapore)’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$340K Buy
+9,433
New +$313K 0.05% 218

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Point72 Asia (Singapore)'s PCVX Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in Vaxcyte (PCVX) in Q3 2025: 9,433 shares worth $340K. The stake represents 0.05% of the portfolio and ranks #218 among its holdings.

285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

  • Point72 Asia (Singapore) held 9,433 shares of Vaxcyte worth $340K as of Q3 2025.
  • Vaxcyte was a new Point72 Asia (Singapore) position in Q3 2025.
  • Vaxcyte made up 0.05% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #218 holding.
  • 285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.